Vaishali Pharma is coming out with an initial public offering (IPO) of 19,76,000 equity shares of face value of Rs 10 each in a price band Rs 71-72 per equity share. The issue opens on August 7, 2017 and will close on August 10, 2017. The shares will be listed on NSE Emerge Platform.
The company will use the issue proceeds for meeting working capital requirement and general corporate purpose.
The book running lead managers to the issue is Pantomath Capital Advisors, while the compliance officer for the issue is Sonal Gandhi.
Vaishali Pharma is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others.
| Company Name | CMP |
|---|---|
| Redington | 218.75 |
| Adani Enterprises | 2500.05 |
| Amrapali Industries | 17.50 |
| Rashi Peripheral | 544.25 |
| PDS | 291.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: